scispace - formally typeset
A

Amanda Jiménez

Researcher at University of Barcelona

Publications -  52
Citations -  1579

Amanda Jiménez is an academic researcher from University of Barcelona. The author has contributed to research in topics: Sleeve gastrectomy & Weight loss. The author has an hindex of 20, co-authored 43 publications receiving 1248 citations. Previous affiliations of Amanda Jiménez include Carlos III Health Institute.

Papers
More filters
Journal ArticleDOI

Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.

TL;DR: Roux-en-Y gastric bypass and SG are associated with comparable remission rates of type 2 diabetes mellitus, however, insufficient weight loss or weight regain in those with a more advanced disease may hamper the benefits of these surgical techniques on T2DM.
Journal ArticleDOI

Individualized Metabolic Surgery Score: Procedure Selection Based on Diabetes Severity.

TL;DR: This is the largest reported cohort with long-term postoperative glycemic follow-up, which categorizes T2DM into 3 validated severity stages for evidence-based procedure selection, and categorizes RYGB was significantly more effective than SG, likely related to its more pronounced neurohormonal effects.
Journal ArticleDOI

GLP-1 Action and Glucose Tolerance in Subjects With Remission of Type 2 Diabetes After Gastric Bypass Surgery

TL;DR: The limited deterioration of glucose tolerance on blockade of GLP-1 action in this study suggests the resolution of T2DM after RYGBP may be explained by mechanisms beyond enhancement ofGLP- 1 action.
Journal ArticleDOI

Protein intake and lean tissue mass retention following bariatric surgery.

TL;DR: The data provide supportive evidence for the PI goals of >60 g/d or 1.1 g/kg IBW/d as a being associated with better LTM preservation in the BS patient.
Journal ArticleDOI

GLP-1 and Glucose Tolerance After Sleeve Gastrectomy in Morbidly Obese Subjects with Type 2 Diabetes

TL;DR: The data suggest the enhanced GLP-1 secretion observed long term after SG is neither sufficient nor critical to maintain normal glucose tolerance in subjects with T2DM antedating the surgery.